Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination.
Gung C, McGuire R, George M, Abdulkareem A, Belden KA, Porcu P, Martinez-Outschoorn U, Binder AF, Chervenova I, Alpdogan O. Gung C, et al. Among authors: alpdogan o. Front Oncol. 2022 Jul 7;12:840451. doi: 10.3389/fonc.2022.840451. eCollection 2022. Front Oncol. 2022. PMID: 35875166 Free PMC article.
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.
Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N. Grosso D, et al. Among authors: alpdogan o, o hara w. Biol Blood Marrow Transplant. 2015 Apr;21(4):646-52. doi: 10.1016/j.bbmt.2014.12.019. Epub 2014 Dec 23. Biol Blood Marrow Transplant. 2015. PMID: 25542159 Free article. Clinical Trial.
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.
Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, Flomenberg N, Grosso D. Gaballa S, et al. Among authors: alpdogan o, o hara w. Biol Blood Marrow Transplant. 2016 Jan;22(1):141-8. doi: 10.1016/j.bbmt.2015.09.017. Epub 2015 Sep 28. Biol Blood Marrow Transplant. 2016. PMID: 26415558 Free article. Clinical Trial.
Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.
Grosso D, Johnson E, Colombe B, Alpdogan O, Carabasi M, Filicko-O'Hara J, Gaballa S, Kasner M, Klumpp T, Martinez-Outschoorn U, Wagner JL, Weiss M, Wang Z, Flomenberg N. Grosso D, et al. Among authors: alpdogan o. Bone Marrow Transplant. 2017 Apr;52(4):615-619. doi: 10.1038/bmt.2016.324. Epub 2017 Jan 9. Bone Marrow Transplant. 2017. PMID: 28067885 No abstract available.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Oluwasanjo A, Kartan S, Johnson W, Alpdogan O, Gru A, Mishra A, Haverkos BM, Gong J, Porcu P. Oluwasanjo A, et al. Among authors: alpdogan o. Cancer Treat Res. 2019;176:83-98. doi: 10.1007/978-3-319-99716-2_4. Cancer Treat Res. 2019. PMID: 30596214 Review.
The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
Kartan S, Johnson WT, Sokol K, Alpdogan O, Gru AA, Nikbakht N, Porcu P. Kartan S, et al. Among authors: alpdogan o. Chin Clin Oncol. 2019 Feb;8(1):3. doi: 10.21037/cco.2018.12.03. Epub 2019 Jan 9. Chin Clin Oncol. 2019. PMID: 30691273 Free article. Review.
Systemic therapy of cutaneous T-cell lymphoma (CTCL).
Alpdogan O, Kartan S, Johnson W, Sokol K, Porcu P. Alpdogan O, et al. Chin Clin Oncol. 2019 Feb;8(1):10. doi: 10.21037/cco.2019.01.02. Chin Clin Oncol. 2019. PMID: 30818958 Free article. Review.
95 results